首页> 外文期刊>The Journal of Physiology >Differential action of bradykininon intrarenal regional perfusion in the rat: waning effect in the cortex and major impact in the medulla
【24h】

Differential action of bradykininon intrarenal regional perfusion in the rat: waning effect in the cortex and major impact in the medulla

机译:缓激肽对大鼠肾内区域灌注的差异作用:皮质的减弱作用和对髓质的主要影响

获取原文
获取原文并翻译 | 示例
       

摘要

The renal kallikrein-kinin system is involved in the control of the intrarenal circulation and arterial pressure but bradykinin (Bk) effects on perfusion of individual kidney zones have not been examined in detail. Effects of Bk infused into renal artery, renal cortex or medulla on perfusion of whole kidney (RBF, renal artery probe) and of the cortex, outer- and inner medulla (CBF, OMBF, IMBF: laser-Doppler fluxes), were examined in anaesthetized rats. Renal artery infusion of Bk, 0.3-0.6 mg kg~(-1) h~(-1), induced no sustained increase in RBF or CBF. OMBF and IMBF increased initially 6 or 16%, respectively; only the IMBF increase (+10%) was sustained. Pre-treatment with l-NAME, 2.4 mg kg~(-1) I.V., prevented the sustained but not initial transient elevation of medullary perfusion. Intracortical Bk infusion, 0.75-1.5 mg kg~(-1) h~(-1), did not alter RBF or CBF but caused a sustained 33% increase in IMBF. Intramedullary Bk, 0.3 mg kg~(-1) h~(-1), did not alter RBF or CBF but caused sustained increases in OMBF (+10%) and IMBF (+23%). These responses were not altered by pre-treatment with 1-aminobenzotriazole, 10 mg kg~(-1) I.V., a cytochrome P-450 (CYP450) inhibitor, but were prevented or significantly attenuated by l-NAME or intramedullary clotrimazole, 3.9 mgkg~(-1) h~(-1), an inhibitor of CYP450 epoxygenase and of calcium-dependent K~+ channels (K_ca)- Thus, cortical vasodilatation induced by Bk is only transient so that the agent is unlikely to control perfusion of the cortex. Bk selectively increases perfusion of the medulla, especially of its inner layer, via activation of the NO system and of K_Ca channels.
机译:肾激肽释放酶激肽系统参与肾内循环和动脉压的控制,但缓激肽(Bk)对单个肾区灌注的作用尚未详细检查。研究了在肾动脉,肾皮质或髓质中注入Bk对全肾(RBF,肾动脉探针)以及皮质,外和内髓质(CBF,OMBF,IMBF:激光多普勒通量)灌注的影响。麻醉的大鼠。肾动脉输注Bk 0.3-0.6 mg kg〜(-1)h〜(-1)不会导致RBF或CBF持续增加。 OMBF和IMBF最初分别增长6%或16%;仅IMBF增长(+ 10%)得以维持。用2.4 mg kg〜(-1)I.V. l-NAME预处理可防止持续但最初的短暂性髓质灌注升高。皮质内Bk输注0.75-1.5 mg kg〜(-1)h〜(-1)不会改变RBF或CBF,但会导致IMBF持续增加33%。 0.3 mg kg〜(-1)h〜(-1)的髓内Bk不会改变RBF或CBF,但会导致OMBF(+ 10%)和IMBF(+ 23%)持续增加。这些反应在用1-氨基苯并三唑(10 mg kg〜(-1)IV,一种细胞色素P-450(CYP450)抑制剂)进行预处理时并未改变,但被I-NAME或髓内克霉唑(3.9 mgkg)预防或减弱了。 〜(-1)h〜(-1),一种CYP450环氧合酶和钙依赖性K〜+通道(K_ca)的抑制剂。因此,Bk诱导的皮质血管舒张只是短暂的,因此该药不太可能控制Hg的灌注。皮质。 Bk通过激活NO系统和K_Ca通道选择性增加髓质,特别是其内层的灌注。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号